Advertisement
Screener

CELCUITY INC. (CELC) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CELCUITY INC. Operating Cash Flow

CELCUITY INC. (CELC) reported Operating Cash Flow of -$110.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13

  • CELCUITY INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$55.43M.
  • CELCUITY INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$55.06M.
  • CELCUITY INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$36.40M.
  • CELCUITY INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$44.82M.
  • CELCUITY INC. net cash provided by (used in) operating activities for fiscal 2025 was -$153.28M.
  • CELCUITY INC. net cash provided by (used in) operating activities for fiscal 2024 was -$83.47M.
  • CELCUITY INC. net cash provided by (used in) operating activities for fiscal 2023 was -$53.81M.
  • CELCUITY INC. net cash provided by (used in) operating activities for fiscal 2022 was -$36.01M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$55.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$110.49M
10-Q · filed 2026-08-13
-$146.89M
derived: sum of 3 quarters · filed 2026-08-13
-$191.71M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$55.06M
10-Q · filed 2026-05-14
-$91.46M
derived: sum of 2 quarters · filed 2026-05-14
-$136.28M
derived: sum of 3 quarters · filed 2026-05-14
-$172.49M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$36.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$81.22M
derived: sum of 2 quarters · filed 2026-03-26
-$117.43M
derived: sum of 3 quarters · filed 2026-08-13
-$153.28M
10-K · filed 2026-03-26
2025-09-30-$44.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$81.03M
derived: sum of 2 quarters · filed 2026-08-13
-$116.88M
10-Q · filed 2025-11-13
-$144.65M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$36.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$72.06M
10-Q · filed 2026-08-13
-$99.83M
derived: sum of 3 quarters · filed 2026-08-13
-$120.40M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$35.85M
10-Q · filed 2026-05-14
-$63.62M
derived: sum of 2 quarters · filed 2026-05-14
-$84.19M
derived: sum of 3 quarters · filed 2026-05-14
-$102.25M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$27.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$48.33M
derived: sum of 2 quarters · filed 2026-03-26
-$66.40M
derived: sum of 3 quarters · filed 2026-03-26
-$83.47M
10-K · filed 2026-03-26
-$83.47M
10-K · filed 2025-03-31
2024-09-30-$20.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$38.63M
derived: sum of 2 quarters · filed 2025-11-13
-$55.70M
10-Q · filed 2025-11-13
-$55.70M
10-Q · filed 2024-11-14
-$74.23M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$18.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$35.13M
10-Q · filed 2025-08-14
-$35.14M
10-Q · filed 2024-08-14
-$53.67M
derived: sum of 3 quarters · filed 2025-08-14
-$66.42M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$17.07M
10-Q · filed 2025-05-15
-$17.07M
10-Q · filed 2024-05-15
-$35.60M
derived: sum of 2 quarters · filed 2025-05-15
-$48.35M
derived: sum of 3 quarters · filed 2025-05-15
-$58.01M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$18.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$31.28M
derived: sum of 2 quarters · filed 2025-03-31
-$40.94M
derived: sum of 3 quarters · filed 2025-03-31
-$53.81M
10-K · filed 2025-03-31
2023-09-30-$12.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$22.41M
derived: sum of 2 quarters · filed 2024-11-14
-$35.28M
10-Q · filed 2024-11-14
-$44.76M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$9.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$22.53M
10-Q · filed 2024-08-14
-$32.01M
derived: sum of 3 quarters · filed 2024-08-14
-$41.32M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$12.87M
10-Q · filed 2024-05-15
-$22.35M
derived: sum of 2 quarters · filed 2024-05-15
-$31.65M
derived: sum of 3 quarters · filed 2024-05-15
-$42.94M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$9.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
-$18.79M
derived: sum of 2 quarters · filed 2024-03-27
-$30.08M
derived: sum of 3 quarters · filed 2024-03-27
-$36.01M
10-K · filed 2024-03-27
2022-09-30-$9.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$20.60M
derived: sum of 2 quarters · filed 2023-11-13
-$26.53M
10-Q · filed 2023-11-13
-$32.65M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$11.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$17.22M
10-Q · filed 2023-08-11
-$23.35M
derived: sum of 3 quarters · filed 2023-08-11
-$27.39M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31-$5.93M
10-Q · filed 2023-05-15
-$12.06M
derived: sum of 2 quarters · filed 2023-05-15
-$16.11M
derived: sum of 3 quarters · filed 2023-05-15
-$23.72M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$6.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$10.17M
derived: sum of 2 quarters · filed 2023-03-23
-$17.79M
derived: sum of 3 quarters · filed 2023-03-23
-$20.31M
10-K · filed 2023-03-23
2021-09-30-$4.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$11.67M
derived: sum of 2 quarters · filed 2022-11-10
-$14.19M
10-Q · filed 2022-11-10
-$16.30M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$7.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$10.14M
10-Q · filed 2022-08-12
-$12.25M
derived: sum of 3 quarters · filed 2022-08-12
-$13.90M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$2.52M
10-Q · filed 2022-05-16
-$4.63M
derived: sum of 2 quarters · filed 2022-05-16
-$6.28M
derived: sum of 3 quarters · filed 2022-05-16
-$7.83M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
-$3.76M
derived: sum of 2 quarters · filed 2022-03-23
-$5.31M
derived: sum of 3 quarters · filed 2022-03-23
-$7.15M
10-K · filed 2022-03-23
2020-09-30-$1.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$3.20M
derived: sum of 2 quarters · filed 2021-11-09
-$5.04M
10-Q · filed 2021-11-09
-$6.74M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$1.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$3.39M
10-Q · filed 2021-08-11
-$5.09M
derived: sum of 3 quarters · filed 2021-08-11
-$6.57M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31-$1.83M
10-Q · filed 2021-05-10
-$3.54M
derived: sum of 2 quarters · filed 2021-05-10
-$5.02M
derived: sum of 3 quarters · filed 2021-05-10
-$6.24M
derived: sum of 4 quarters · filed 2021-05-10
2019-12-31-$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
-$3.18M
derived: sum of 2 quarters · filed 2021-02-16
-$4.41M
derived: sum of 3 quarters · filed 2021-02-16
-$6.00M
10-K · filed 2021-02-16
2019-09-30-$1.48M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09
-$2.70M
derived: sum of 2 quarters · filed 2020-11-09
-$4.29M
10-Q · filed 2020-11-09
-$5.81M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$1.23M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-11
-$2.82M
10-Q/A · filed 2020-08-11
-$4.34M
derived: sum of 3 quarters · filed 2020-08-11
-$6.11M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31-$1.59M
10-Q · filed 2020-05-07
-$3.11M
derived: sum of 2 quarters · filed 2020-05-07
-$4.88M
derived: sum of 3 quarters · filed 2020-05-07
-$6.22M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$3.29M
derived: sum of 2 quarters · filed 2020-03-13
-$4.63M
derived: sum of 3 quarters · filed 2020-03-13
-$6.08M
10-K · filed 2020-03-13
2018-09-30-$1.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$3.11M
derived: sum of 2 quarters · filed 2019-11-07
-$4.56M
10-Q · filed 2019-11-07
-$5.67M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$1.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$2.78M
10-Q · filed 2019-08-08
-$3.89M
derived: sum of 3 quarters · filed 2019-08-08
-$5.52M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$1.45M
10-Q · filed 2019-05-07
-$2.56M
derived: sum of 2 quarters · filed 2019-05-07
-$4.19M
derived: sum of 3 quarters · filed 2019-05-07
-$5.45M
derived: sum of 4 quarters · filed 2019-05-07
2017-12-31-$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$2.74M
derived: sum of 2 quarters · filed 2019-03-01
-$4.00M
derived: sum of 3 quarters · filed 2019-03-01
-$4.95M
10-K · filed 2019-03-01
2017-09-30-$1.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$2.89M
derived: sum of 2 quarters · filed 2018-11-13
-$3.84M
10-Q · filed 2018-11-13
-$4.54M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$2.21M
10-Q · filed 2018-08-09
-$2.91M
derived: sum of 3 quarters · filed 2018-08-09
2017-03-31-$947.14K
10-Q · filed 2018-05-14
-$1.65M
derived: sum of 2 quarters · filed 2018-05-14
2016-12-31-$704.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$2.89M
10-K · filed 2018-03-15
2016-09-30-$2.18M
10-Q · filed 2017-12-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B